Think tank opens a novel food regulatory learning platform after the Biotech Act left sandboxes out
New Foods RegLab guides up to 10 companies on EU novel food strategy. Authorisation averages two and a half years against a statutory 18 to 24 months.
The Ministry of Future Affairs, a European think tank, has launched the New Foods RegLab, an opt-in regulatory learning platform for companies preparing novel food applications in the European Union. It covers products that fall under the novel food regulation, including cultivated meat and precision-fermented proteins. The first cohort takes up to 10 non-competing companies through a two-day programme in Brussels on 19 and 20 January 2027. Applications close on 30 November 2026 and companies based outside the EU may apply, with UK firms explicitly encouraged. FoodNavigator reported the launch on 15 October 2026, and NutraIngredients, FoodBev Media and Green Queen covered it the same day.
The case for the platform rests on the gap between the statutory clock and the real one. EU novel food authorisation is meant to take 18 to 24 months. The actual average runs at about two and a half years, and some applications have taken more than five years. The Ministry attributes that gap to knowledge transfer and process design rather than to the authorisation rules themselves: applicants cannot easily anticipate what the European Food Safety Authority will ask for, so dossiers go out incomplete and come back with data requests. Anna Handschuh, founder and managing director of the Ministry of Future Affairs, put the applicant's problem as not being able to know in advance what EFSA will ask for, and said of the timelines that “The urgency is real.”
What the RegLab is not is a regulatory sandbox in the legal sense. It is not run by regulators and it relaxes no rules, so nothing a participant does inside it changes its position in a live authorisation. The programme is run on the Ministry's behalf by Atova Regulatory Consulting, using experts with more than 15 years of experience taking novel food dossiers through EU authorisation. Each participant gets a structured review of its regulatory position and strategy, alongside a policy session on pre-submission advice. Sessions run under the Chatham House Rule, and anonymised findings go to EFSA and the European Commission as policy recommendations. Support comes from the Dutch Province of Zuid-Holland, the Limburg Development and Investment Company and ROM-Nederland. Participants do not need a complete dossier or a finished regulatory strategy to join.
The timing is the political point. When the European Commission proposed the Biotech Act, it left novel foods out of the regulatory sandboxes the act would create, citing “ethical or cultural concerns among various consumer segments.” Trade groups, member states and MEPs pushed back, and the question is still live in Parliament and Council. The RegLab arrives as a prototype in that gap, built to find where the current framework actually breaks and to feed that evidence into the pre-submission advice the EU has signalled it wants to broaden. Handschuh said the aim is to inform rather than to replace: “We hope to inspire and to inform the future EU pre-submission advice,” and “What we want to inspire is that there is a continuous learning cycle in the interest of the consumers.” The design borrows from the UK Food Standards Agency's cultivated meat sandbox, and the accompanying paper, “Building on Draghi: Regulatory Learning With The New Foods RegLab,” proposes opt-in learning platforms across member states.
What this means for AgTech founders: the regulatory clock is a financing variable, and this is the first credible attempt to make it legible before you spend money on it. A novel food company raising a Series A on an 18 to 24 month authorisation assumption and landing at 30 months has not hit a regulatory problem, it has hit a runway problem, and the two look identical to a board. The honest value of two days in Brussels is not approval or speed, because the RegLab cannot deliver either. It is a sharper estimate of what EFSA will ask you for, which is the input your model is currently guessing at. That is worth real money if it moves your dossier from one data request cycle to none, and worth considerably less if your regulatory strategy is already written by people who have done this before. Weigh the cost accordingly: ten slots, a November deadline, and Chatham House cover that lets you discuss a dossier you would not discuss on a panel. The strategic read matters more than the workshop. Novel foods were cut out of the Biotech Act sandboxes on cultural rather than scientific grounds, which tells you the bottleneck in this sector is political and will be settled in Parliament and Council, not in a lab. A platform that routes anonymised evidence from ten real dossiers to EFSA and the Commission is one of the few mechanisms through which an early-stage company's experience reaches that argument at all. Founders who treat regulatory affairs as a cost centre to be minimised should note that the firms shaping the rules they will operate under are in the room, and that participation costs two days rather than a lobbying budget.
Think tank opens a novel food regulatory learning platform after the Biotech Act left sandboxes out
The New Foods RegLab will take up to 10 non-competing companies through two days in Brussels in January 2027, with applications closing on 30 November 2026, and will pass anonymised findings to EFSA and the European Commission.
The Ministry of Future Affairs, a European think tank, has launched the New Foods RegLab, an opt-in regulatory learning platform for companies preparing novel food applications in the European Union. It covers products that fall under the novel food regulation, including cultivated meat and precision-fermented proteins. The first cohort takes up to 10 non-competing companies through a two-day programme in Brussels on 19 and 20 January 2027. Applications close on 30 November 2026 and companies based outside the EU may apply, with UK firms explicitly encouraged. FoodNavigator reported the launch on 15 October 2026, and NutraIngredients, FoodBev Media and Green Queen covered it the same day.
The case for the platform rests on the gap between the statutory clock and the real one. EU novel food authorisation is meant to take 18 to 24 months. The actual average runs at about two and a half years, and some applications have taken more than five years. The Ministry attributes that gap to knowledge transfer and process design rather than to the authorisation rules themselves: applicants cannot easily anticipate what the European Food Safety Authority will ask for, so dossiers go out incomplete and come back with data requests. Anna Handschuh, founder and managing director of the Ministry of Future Affairs, put the applicant's problem as not being able to know in advance what EFSA will ask for, and said of the timelines that “The urgency is real.”
What the RegLab is not is a regulatory sandbox in the legal sense. It is not run by regulators and it relaxes no rules, so nothing a participant does inside it changes its position in a live authorisation. The programme is run on the Ministry's behalf by Atova Regulatory Consulting, using experts with more than 15 years of experience taking novel food dossiers through EU authorisation. Each participant gets a structured review of its regulatory position and strategy, alongside a policy session on pre-submission advice. Sessions run under the Chatham House Rule, and anonymised findings go to EFSA and the European Commission as policy recommendations. Support comes from the Dutch Province of Zuid-Holland, the Limburg Development and Investment Company and ROM-Nederland. Participants do not need a complete dossier or a finished regulatory strategy to join.
The timing is the political point. When the European Commission proposed the Biotech Act, it left novel foods out of the regulatory sandboxes the act would create, citing “ethical or cultural concerns among various consumer segments.” Trade groups, member states and MEPs pushed back, and the question is still live in Parliament and Council. The RegLab arrives as a prototype in that gap, built to find where the current framework actually breaks and to feed that evidence into the pre-submission advice the EU has signalled it wants to broaden. Handschuh said the aim is to inform rather than to replace: “We hope to inspire and to inform the future EU pre-submission advice,” and “What we want to inspire is that there is a continuous learning cycle in the interest of the consumers.” The design borrows from the UK Food Standards Agency's cultivated meat sandbox, and the accompanying paper, “Building on Draghi: Regulatory Learning With The New Foods RegLab,” proposes opt-in learning platforms across member states.
What this means for AgTech founders: the regulatory clock is a financing variable, and this is the first credible attempt to make it legible before you spend money on it. A novel food company raising a Series A on an 18 to 24 month authorisation assumption and landing at 30 months has not hit a regulatory problem, it has hit a runway problem, and the two look identical to a board. The honest value of two days in Brussels is not approval or speed, because the RegLab cannot deliver either. It is a sharper estimate of what EFSA will ask you for, which is the input your model is currently guessing at. That is worth real money if it moves your dossier from one data request cycle to none, and worth considerably less if your regulatory strategy is already written by people who have done this before. Weigh the cost accordingly: ten slots, a November deadline, and Chatham House cover that lets you discuss a dossier you would not discuss on a panel. The strategic read matters more than the workshop. Novel foods were cut out of the Biotech Act sandboxes on cultural rather than scientific grounds, which tells you the bottleneck in this sector is political and will be settled in Parliament and Council, not in a lab. A platform that routes anonymised evidence from ten real dossiers to EFSA and the Commission is one of the few mechanisms through which an early-stage company's experience reaches that argument at all. Founders who treat regulatory affairs as a cost centre to be minimised should note that the firms shaping the rules they will operate under are in the room, and that participation costs two days rather than a lobbying budget.
